Research output per year
Research output per year
- 14 results
Search results
-
2024
Multi-array miRNA approach and associated protein expression profiling for the development of predictive and prognostic biomarkers in esophageal adenocarcinoma
Neureiter, D., Mayr, C. R., Neureiter, E., Winkelmann, P., Neumayer, B., Klieser, E., Wagner, A., Hufnagl, C., Emmanuel, K., Holzinger, J., Koch, O. O., Kiesslich, T. & Varga, M., Feb 2024, In: Oncology Research and Treatment. 2024, 47, p. 70 1 p., 493.Research output: Contribution to journal › Abstract (Journal) › peer-review
-
2022
Endothelin-1 genetic polymorphism (SNP rs5370-TT) fails to predict resistance to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial
Gampenrieder, S. P., Steiner, M., Hufnagl, C., Hackl, H., Rinnerthaler, G., Westphal, T., Huemer, F., Monzo-Fuentes, C., Morre, P., Hauser-Kronberger, C. & Greil, R., 2022, In: ANNALS OF ONCOLOGY . 33, p. S141-S141Research output: Contribution to journal › Abstract (Journal) › peer-review
-
2019
A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial
Gampenrieder, S. P., Angela, R., Rinnerthaler, G., Hackl, H., Steiner, M., Pulverer, W., Weinhaeusel, A., Klinglmayr, E., Karl, T., Ilic, S., Hufnagl, C., Hauser-Kronberger, C., Egle, A. & Greil, R., 2019, In: CANCER RESEARCH . 79, 4Research output: Contribution to journal › Abstract (Journal) › peer-review
-
2018
Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer
Hufnagl, C., Leisch, M., Weiss, L., Melchardt, T., Moik, M., Geisberger, R., Asslaber, D., Steininger, P., Meissnitzer, T., Neureiter, D., Greil, R. & Egle, A., 2018, In: Oncology Research and Treatment. 41, p. 307-307Research output: Contribution to journal › Abstract (Journal) › peer-review
-
Interlaboratory comparison of a KIT D816V detection assay in patients with systemic mastocytosis by chip-based digital PCR
Naumann, N., Hoffmann, O., Bugert, P., Schwaab, J., Fabarius, A., Metzgeroth, G., Reiter, L., Haselmann, V., Schneider, S., Kristensen, T., Hufnagl, C., Sotlar, K., Hofmann, W., Reiter, A. & Jawhar, M., 2018, In: Oncology Research and Treatment. 41, p. 99-99Research output: Contribution to journal › Abstract (Journal) › peer-review
-
2017
DNA methylation signature predicting bevacizumab efficacy in metastatic breast cancer
Gampenrieder, S. P., Rinnerthaler, G., Pulverer, W., Weinhusel, A., Hufnagl, C., Hackl, H., Hauser-Kronberger, C., Mlineritsch, B. & Greil, R., 2017, In: CANCER RESEARCH . 77Research output: Contribution to journal › Abstract (Journal) › peer-review
-
Low expression of miR-20a-5p predicts benefit to bevacizumab in metastatic breast cancer patients treated within the TANIA trial
Gampenrieder, S., Rinnerthaler, G., Hackl, H., Steiner, M., Fuentes, C., Hufnagl, C., Hauser-Kronberger, C., Egle, A. & Greil, R., 2017, In: ANNALS OF ONCOLOGY . 28Research output: Contribution to journal › Abstract (Journal) › peer-review
1 Citation (Web of Science) -
2016
Tissue microRNAs predicting the pattern of breast cancer metastases
Gampenrieder, S. P., Hackl, H., Rinnerthaler, G., Steiner, M., Hufnagl, C., Hauser-Kronberger, C., Mlineritsch, B. & Greil, R., 2016, In: EUROPEAN JOURNAL OF CANCER . 57, p. S111-S111Research output: Contribution to journal › Abstract (Journal) › peer-review
-
2015
MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer
Gampenrieder, S., Hamacher, F., Rinnerthaler, G., Hufnagl, C., Hackl, H., Romeder, F., Muss, C., Hauser-Kronbeger, C., Mlineritsch, B. & Greil, R., 2015, In: CANCER RESEARCH . 75, 9Research output: Contribution to journal › Abstract (Journal) › peer-review
1 Citation (Web of Science) -
2014
Clonal Evolution in Relapsed or Refractory Diffuse Large B Cell Lymphoma
Melchardt, T., Hufnagl, C., Weigert, O., Weinstock, D., Kopp, N., Weiss, L., Neureiter, D., Trankenschuh, W., Hackl, H., Greil, R. & Egle, A., 2014, In: BLOOD . 124, 21Research output: Contribution to journal › Abstract (Journal) › peer-review
-
Spliceosome Mediated RNA Trans-Splicing for Targeting Kappa(+) B-Cell Neoplasms
Weiss, L., Gruber, C., Koller, U., Pinon-Hofbauer, J., Hainzl, S., Hufnagl, C., Melchardt, T., Brachtl, G., Greil, R., Bauer, J. & Egle, A., 2014, In: BLOOD . 124, 21Research output: Contribution to journal › Abstract (Journal) › peer-review
-
2013
Lapatinib plus Caelyx in patients with advanced or metastatic Her 2 positive breast cancer following failure of Trastuzumab therapy - A Phase II study of the Arbeitsgemeinschaft Medikamentose Tumortherapie
Pircher, M., Mlineritsch, B., Fridrik, M., Dittrich, C., Lang, A., Petru, E., Weltermann, A., Thaler, J., Hufnagl, C., Gampenrieder, S., Ressler, S., Rinnerthaler, G., Ulmer, H. & Greil, R., 2013, In: ONKOLOGIE . 36, p. 159-159Research output: Contribution to journal › Abstract (Journal) › peer-review
-
2012
Feasibility of anthracycline based treatment in unselected elderly DLBCL patients
Melchardt, T., Weiss, L., Hufnagl, C., Neureiter, D., Kemmerling, R., Hopfinger, G., Greil, R. & Egle, A., 2012, In: ONKOLOGIE . 35, p. 86-87Research output: Contribution to journal › Abstract (Journal) › peer-review
-
Treatment of Aggressive B-Cell Lymphoma in the Elderly: The Influence of SNPs Affecting Pharmacodynamics Is Different Compared to Younger Patient
Melchardt, T., Weiss, L., Hufnagl, C., Neureiter, D., Kemmerling, R., Morre, P., Boekstegers, A., Hopfinger, G., Greil, R. & Egle, A., 2012, In: BLOOD . 120, 21Research output: Contribution to journal › Abstract (Journal) › peer-review